跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbemed - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbemed
Approved
STANDARD
Irbemed
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ef1c886bb256a811
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
ef1c886bb256a811
Drug Approval Philippines Name
Irbemed
Product Name
Irbemed
Registration Number
DR-XY43874
Brand Name
Irbemed
Generic Name
Irbesartan
Dosage Form
Film-Coated Tablet
Dosage Strength
150 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Ultramed Pharma, Inc.
Issuance Date
25 July 2024
Expiry Date
11 November 2029
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ef1c886bb256a811
Type
Standard
Back to Philippines FDA Approvals